| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.700 | None | 0.993 | 138 | 4 | 1995 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.600 | None | 0.964 | 362 | 1 | 1992 | 2020 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
group | 0.500 | None | 0.949 | 195 | 22 | 1998 | 2020 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
group | 0.500 | None | 0.947 | 75 | 10 | 2006 | 2020 | ||||||||
|
autophagy related 16 like 1 | 0.543 | 0.769 | 0.96 |
|
group | 0.500 | None | 0.974 | 38 | 5 | 2007 | 2020 | ||||||||
|
TNF superfamily member 15 | 0.531 | 0.692 | 2.8E-03 |
|
group | 0.500 | None | 0.971 | 35 | 6 | 2003 | 2020 | ||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
group | 0.500 | None | 1.000 | 16 | 3 | 2008 | 2017 | |||||||||
|
caspase recruitment domain family member 9 | 0.566 | 0.654 | 8.1E-13 |
|
group | 0.500 | None | 0.938 | 16 | 2 | 2009 | 2020 | ||||||||
|
innate immunity activator | 0.743 | 0.346 | 2.2E-04 |
|
group | 0.420 | None | 1.000 | 6 | 2 | 2011 | 2018 | ||||||||
|
interleukin 18 receptor accessory protein | 0.674 | 0.577 | 2.2E-03 |
|
group | 0.410 | None | 1.000 | 3 | 2 | 2008 | 2015 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.400 | None | 0.980 | 50 | 0 | 1992 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.400 | None | 0.972 | 36 | 2 | 2006 | 2019 | ||||||||
|
interleukin 10 receptor subunit alpha | 0.579 | 0.692 | 1.8E-02 |
|
group | 0.400 | strong | 1.000 | 21 | 1 | 2012 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
group | 0.400 | None | 1.000 | 19 | 3 | 1995 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 18 | 0 | 1998 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.400 | None | 1.000 | 16 | 1 | 2001 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
group | 0.400 | None | 0.714 | 14 | 1 | 2005 | 2019 | ||||||||
|
X-linked inhibitor of apoptosis | 0.447 | 0.808 | 0.92 |
|
group | 0.400 | strong | 1.000 | 12 | 0 | 2012 | 2020 | ||||||||
|
mucin 19, oligomeric | 0.736 | 0.615 | 6.2E-32 |
|
group | 0.400 | None | 1.000 | 2 | 1 | 2011 | 2012 | ||||||||
|
phospholipase C gamma 2 | 0.588 | 0.808 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.370 | None | 0.875 | 8 | 2 | 1997 | 2016 | ||||||||
|
interleukin 10 receptor subunit beta | 0.636 | 0.577 | 2.5E-06 |
|
group | 0.360 | strong | 1.000 | 7 | 0 | 2011 | 2020 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
group | 0.350 | None | 1.000 | 7 | 1 | 2004 | 2015 | ||||||||
|
solute carrier family 11 member 1 | 0.525 | 0.846 | 1.5E-19 |
|
group | 0.350 | None | 0.667 | 6 | 2 | 1999 | 2010 | ||||||||
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.579 | 0.654 | 1.00 |
|
group | 0.340 | None | 0.800 | 5 | 2 | 2009 | 2017 |